Showing results (121-130 of 184) with videos related to
Sort By:
Pageof 19
Cardiovascular Drugs and Therapy|January 10, 2020
Absence of Functional Na<sub>v</sub>1.8 Channels in Non-diseased Atrial and Ventricular CardiomyocytesSimona Casini, Gerard A Marchal, Makiri Kawasaki, et al.Journal of the American College of Cardiology|April 18, 2015
Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trialReinoud E Knops, Fleur V Y Tjong, Petr Neuzil, et al.Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 17, 2023
Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patientsLinghe Wu, Zhu Jiang, Eva R Meulendijks, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 13, 2018
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) studyRaffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.JACC. Clinical Electrophysiology|March 23, 2019
Additional Ganglion Plexus Ablation During Thoracoscopic Surgical Ablation of Advanced Atrial Fibrillation: Intermediate Follow-Up of the AFACT StudyWouter R Berger, Jolien Neefs, Nicoline W E van den Berg, et al.Frontiers in Cardiovascular Medicine|March 19, 2025
Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillationEva R Meulendijks, Manouck J M Roelofs, Tim A C de Vries, et al.JCI Insight|August 21, 2020
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablationJasmeet S Reyat, Winnie Chua, Victor R Cardoso, et al.International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 22, 2023
The influence of atrial high-rate episodes on stroke and cardiovascular death: an updateTobias Toennis, Emanuele Bertaglia, Axel Brandes, et al.BMC Cardiovascular Disorders|July 14, 2019
Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)Raffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.Pageof 19